vs
NEUROCRINE BIOSCIENCES INC（NBIX）与Rackspace Technology, Inc.（RXT）财务数据对比。点击上方公司名可切换其他公司
NEUROCRINE BIOSCIENCES INC的季度营收约是Rackspace Technology, Inc.的1.2倍（$805.5M vs $682.8M），NEUROCRINE BIOSCIENCES INC净利率更高（19.1% vs -4.8%，领先23.9%），NEUROCRINE BIOSCIENCES INC同比增速更快（28.3% vs -0.4%），NEUROCRINE BIOSCIENCES INC自由现金流更多（$386.0M vs $56.0M），过去两年NEUROCRINE BIOSCIENCES INC的营收复合增速更高（25.0% vs -0.6%）
Neurocrine Biosciences是1992年成立的美国生物制药企业，总部位于加利福尼亚州圣地亚哥，截至2024年10月首席执行官为Kyle Gano。公司专注于神经及内分泌相关疾病的疗法研发，旗下药物缬苯那嗪（商品名Ingrezza）于2017年获美国批准，用于治疗成人迟发性运动障碍。
Rackspace Technology, Inc.是总部位于美国得克萨斯州圣安东尼奥的云计算企业，在弗吉尼亚州雷斯顿以及澳大利亚、加拿大、英国、印度、迪拜、瑞士、荷兰、德国、新加坡、墨西哥、中国香港等多个国家和地区设有办事处，数据中心分布于全球多个主要城市，为客户提供专业的云计算相关服务。
NBIX vs RXT — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $805.5M | $682.8M |
| 净利润 | $153.7M | $-32.7M |
| 毛利率 | 97.8% | 17.6% |
| 营业利润率 | 26.2% | -0.5% |
| 净利率 | 19.1% | -4.8% |
| 营收同比 | 28.3% | -0.4% |
| 净利润同比 | 49.1% | 41.6% |
| 每股收益（稀释后） | $1.49 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $805.5M | $682.8M | ||
| Q3 25 | $794.9M | $671.2M | ||
| Q2 25 | $687.5M | $666.3M | ||
| Q1 25 | $572.6M | $665.4M | ||
| Q4 24 | $627.7M | $685.6M | ||
| Q3 24 | $622.1M | $675.8M | ||
| Q2 24 | $590.2M | $684.9M | ||
| Q1 24 | $515.3M | $690.8M |
| Q4 25 | $153.7M | $-32.7M | ||
| Q3 25 | $209.5M | $-67.1M | ||
| Q2 25 | $107.5M | $-54.5M | ||
| Q1 25 | $7.9M | $-71.5M | ||
| Q4 24 | $103.1M | $-56.0M | ||
| Q3 24 | $129.8M | $-186.6M | ||
| Q2 24 | $65.0M | $25.0M | ||
| Q1 24 | $43.4M | $-640.6M |
| Q4 25 | 97.8% | 17.6% | ||
| Q3 25 | 98.2% | 19.4% | ||
| Q2 25 | 98.4% | 19.4% | ||
| Q1 25 | 98.4% | 19.1% | ||
| Q4 24 | 98.5% | 19.2% | ||
| Q3 24 | 98.7% | 20.3% | ||
| Q2 24 | 98.4% | 19.2% | ||
| Q1 24 | 98.5% | 19.2% |
| Q4 25 | 26.2% | -0.5% | ||
| Q3 25 | 30.1% | -5.1% | ||
| Q2 25 | 21.2% | -3.8% | ||
| Q1 25 | 4.1% | -5.8% | ||
| Q4 24 | 22.6% | -4.2% | ||
| Q3 24 | 29.5% | -25.7% | ||
| Q2 24 | 24.6% | -7.9% | ||
| Q1 24 | 19.3% | -94.5% |
| Q4 25 | 19.1% | -4.8% | ||
| Q3 25 | 26.4% | -10.0% | ||
| Q2 25 | 15.6% | -8.2% | ||
| Q1 25 | 1.4% | -10.7% | ||
| Q4 24 | 16.4% | -8.2% | ||
| Q3 24 | 20.9% | -27.6% | ||
| Q2 24 | 11.0% | 3.7% | ||
| Q1 24 | 8.4% | -92.7% |
| Q4 25 | $1.49 | $-0.13 | ||
| Q3 25 | $2.04 | $-0.28 | ||
| Q2 25 | $1.06 | $-0.23 | ||
| Q1 25 | $0.08 | $-0.31 | ||
| Q4 24 | $1.00 | $-0.20 | ||
| Q3 24 | $1.24 | $-0.82 | ||
| Q2 24 | $0.63 | $0.11 | ||
| Q1 24 | $0.42 | $-2.91 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $713.0M | $105.8M |
| 总债务越低越好 | — | $2.7B |
| 股东权益账面价值 | $3.3B | $-1.2B |
| 总资产 | $4.6B | $2.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $713.0M | $105.8M | ||
| Q3 25 | $340.2M | $99.5M | ||
| Q2 25 | $264.0M | $103.9M | ||
| Q1 25 | $194.1M | $128.0M | ||
| Q4 24 | $233.0M | $144.0M | ||
| Q3 24 | $349.1M | $157.1M | ||
| Q2 24 | $139.7M | $190.2M | ||
| Q1 24 | $396.3M | $282.6M |
| Q4 25 | — | $2.7B | ||
| Q3 25 | — | $2.8B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | — | $3.0B |
| Q4 25 | $3.3B | $-1.2B | ||
| Q3 25 | $3.0B | $-1.2B | ||
| Q2 25 | $2.7B | $-1.1B | ||
| Q1 25 | $2.5B | $-1.1B | ||
| Q4 24 | $2.6B | $-1.0B | ||
| Q3 24 | $2.7B | $-949.7M | ||
| Q2 24 | $2.5B | $-756.2M | ||
| Q1 24 | $2.4B | $-787.2M |
| Q4 25 | $4.6B | $2.8B | ||
| Q3 25 | $4.3B | $2.8B | ||
| Q2 25 | $3.9B | $2.9B | ||
| Q1 25 | $3.7B | $3.0B | ||
| Q4 24 | $3.7B | $3.1B | ||
| Q3 24 | $3.5B | $3.1B | ||
| Q2 24 | $3.3B | $3.4B | ||
| Q1 24 | $3.5B | $3.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $388.4M | $59.7M |
| 自由现金流经营现金流 - 资本支出 | $386.0M | $56.0M |
| 自由现金流率自由现金流/营收 | 47.9% | 8.2% |
| 资本支出强度资本支出/营收 | 0.3% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.53× | — |
| 过去12个月自由现金流最近4个季度 | $743.9M | $90.6M |
8季度趋势，按日历期对齐
| Q4 25 | $388.4M | $59.7M | ||
| Q3 25 | $227.5M | $70.7M | ||
| Q2 25 | $102.0M | $8.4M | ||
| Q1 25 | $64.8M | $12.6M | ||
| Q4 24 | $242.5M | $54.3M | ||
| Q3 24 | $158.0M | $51.8M | ||
| Q2 24 | $64.6M | $24.1M | ||
| Q1 24 | $130.3M | $-90.3M |
| Q4 25 | $386.0M | $56.0M | ||
| Q3 25 | $214.3M | $42.7M | ||
| Q2 25 | $89.5M | $-12.4M | ||
| Q1 25 | $54.1M | $4.3M | ||
| Q4 24 | $235.2M | $34.4M | ||
| Q3 24 | $149.9M | $27.3M | ||
| Q2 24 | $53.0M | $-14.5M | ||
| Q1 24 | $119.1M | $-118.4M |
| Q4 25 | 47.9% | 8.2% | ||
| Q3 25 | 27.0% | 6.4% | ||
| Q2 25 | 13.0% | -1.9% | ||
| Q1 25 | 9.4% | 0.6% | ||
| Q4 24 | 37.5% | 5.0% | ||
| Q3 24 | 24.1% | 4.0% | ||
| Q2 24 | 9.0% | -2.1% | ||
| Q1 24 | 23.1% | -17.1% |
| Q4 25 | 0.3% | 0.5% | ||
| Q3 25 | 1.7% | 4.2% | ||
| Q2 25 | 1.8% | 3.1% | ||
| Q1 25 | 1.9% | 1.2% | ||
| Q4 24 | 1.2% | 2.9% | ||
| Q3 24 | 1.3% | 3.6% | ||
| Q2 24 | 2.0% | 5.6% | ||
| Q1 24 | 2.2% | 4.1% |
| Q4 25 | 2.53× | — | ||
| Q3 25 | 1.09× | — | ||
| Q2 25 | 0.95× | — | ||
| Q1 25 | 8.20× | — | ||
| Q4 24 | 2.35× | — | ||
| Q3 24 | 1.22× | — | ||
| Q2 24 | 0.99× | 0.96× | ||
| Q1 24 | 3.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NBIX
| INGREZZA Net Product Sales | $653.8M | 81% |
| CRENESSITY Net Product Sales | $135.4M | 17% |
| Other Income | $12.6M | 2% |
| Collaboration Revenue | $7.2M | 1% |
RXT
| Public Cloud Services Segment | $442.2M | 65% |
| Private Cloud Service Segment | $240.6M | 35% |
